FL oncologist accused of diluting Lupron
Compliance Monitor, February 4, 2003
Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!
A federal grand jury indicted a Florida oncologist on January 29 for allegedly diluting the cancer drug Lupron, and reselling it on the wholesale market illegally, according to Marcos Jimenez, U.S. attorney for Florida's southern district.
Victor Souaid faces up to 10 years in prison and a $250,000 fine if convicted. Federal prosecutors accused him of tampering with the pre-filled Lupron syringes and diluting the drug so a single dose could be re-used on more than one patient. He allegedly billed his patients' health insurance carriers for the full dose, according to Jimenez.
Souaid is also accused of illegally selling Lupron on the wholesale market when he didn't have a license to do so. Jimenez estimates that Souaid made more than $1.5 million in illegally sold Lupron.
Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!
Related Products
-
Strategies for Health Care Compliance
News and real-life examples to increase the effectiveness of your compliance program. Strategies for Health Care Compliance...
-
Compliance Monitor
This HTML e-mail newsletter delivers news on Medicare and Medicaid fraud and abuse, as well as recent documents and targets...
-
Medicare Weekly Update
Each issue of Medicare Weekly Update includes the latest CMS proposed and final rules, CMS manual revisions, and...
-
Medicare Update for Physician Services
Medicare Update for Physician Services is a free, monthly e-zine that delivers news and information to help physician...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Identify potential Medicaid RAC target areas
- Capturing all necessary codes for IUD insertion and removal can be challenging
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- OB services: Coding inside and outside of the package
- Q/A: Coding infusions to correct low potassium levels
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- CMS has reformulated payments for some bilateral procedures
- Q&A: Follow CMS' coding guidelines when using modifier -25
- Understand the spine to code back procedures correctly
- What does case-mix index mean to you?
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q/A. One injection code or two?
- Searched